Upgrade to SI Premium - Free Trial

Stifel Reiterates Buy Rating on Boston Scientific (BSX), 'would not view a cybersecurity-related guidance change as reflecting negatively'

August 26, 2026 8:22 AM
Stifel analyst Rick Wise reiterated a Buy rating and $60.00 price target on Boston Scientific (NYSE: BSX).The analyst commented: "This ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles